Company intelligence / Profile preview

Rokline Health Concepts

Houston, Texas, United Statesprofiles.biocentury.com ↗

Ownership: Private
Development stage: Other

Overview

Rokline Health Concepts is developing a spider silk protein-based treatment for refractory wounds in partnership with Medicos Biotech, aiming to initiate clinical trials and seek FDA approval within three years. The company has also licensed the SHERLOCK CRISPR platform to develop high-throughput COVID‑19 diagnostic tests, contributing to pandemic response efforts. No published clinical results yet on the wound-healing program; the COVID‑19 test leverages an already authorized technology[1][2][4][5].

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Protein (spider silk protein-based therapy)Diagnostic device (CRISPR-based diagnostics)
Industry: Biotech

Partnerships

Medicos Biotech (joint venture partner on spider silk program)[4][5]Sherlock Biosciences/The 221b Foundation (licensee of SHERLOCK CRISPR platform)[2]

Beyond the preview

Go deeper on Rokline Health Concepts.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rokline Health Concepts.

Explore the full profile